HLA Micropolymorphisms Strongly Affect Peptide–MHC Multimer–Based Monitoring of Antigen-Specific CD8+ T Cell Responses
Marit M. van Buuren(The Netherlands Cancer Institute), Ton N. Schumacher(Leiden University Medical Center), Pia Kvistborg(The Netherlands Cancer Institute), Feline E. Dijkgraaf(The Netherlands Cancer Institute), Mireille Toebes(The Netherlands Cancer Institute), Mélanie Nguyen(Merck KGaA, Darmstadt (Germany)), Cynthia Xin Lei Chang(National University of Singapore), Gijsbert M. Grotenbreg, Juk Yee Mok(Sanquin), Carsten Linnemann(The Netherlands Cancer Institute), Wim J.E. van Esch(Sanquin)
Cited by 16
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
|Journal of Clinical Oncology|2013|799
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
|Nature|2017|697
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
|Nature Medicine|2014|692
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
|Nature Medicine|2018|572